Work

Extremely large outlier treatment effects may be a footprint of bias in trials from less developed countries: randomized trials of gabapentinoids

Year: 2018

Type: article

Source: Journal of Clinical Epidemiology

DOI: 10.1016/j.jclinepi.2018.10.012

Authors: Karishma Desai, Ian Carroll, Steven Asch, Tina Hernandez-Boussard, John P.A. Ioannidis

Institutions: Stanford Medicine, Stanford University, VA Palo Alto Health Care System

Language: English

Topic: Pharmaceutical industry and healthcare

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Agency for Healthcare Research and Quality

Award: G2138497341

OpenAlex ID: W2897552013

FWCI: 1.926

Cites: 25

Cited by: 12

Related to: 10